Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (7): 990-1000.doi: 10.12092/j.issn.1009-2501.2026.07.015

Previous Articles     Next Articles

Cold exposure-induced pathophysiological changes and related diseases: recent advances

Shunfang ZUO1(), Huali XU1, Linyu LI1, Tianlang LI1, Wenwen FU1,*(), Yan XUE2,*()   

  1. 1. Department of Pharmacology, School of Pharmacy, Jilin University, Changchun 130021, Jilin, China
    2. Department of Burns Surgery, First Hospital, Jilin University, Changchun 130021, Jilin, China
  • Received:2025-08-16 Revised:2025-12-25 Online:2026-07-26 Published:2026-08-04
  • Contact: Wenwen FU,Yan XUE E-mail:zuosf23@mails.jlu.edu.cn;fww@jlu.edu.cn;xueyan0905@jlu.edu.cn

Abstract:

Under cold conditions, organism activate the hypothalamic thermoregulatory center, initiating a neuroendocrine-metabolic cascade to maintain core body temperature homeostasis. This process simultaneously induces both adaptive and pathophysiological alterations. Cold exposure triggers key pathophysiological including enhanced thermogenesis, energy metabolism reprogramming, vasomotor dysfunction, immune regulation imbalance, overactivation of renin-angiotensin-aldosterone system (RAAS), and multi-system damage and dysfunction. These alterations are closely associated with the development and progression of frostbite, cardiovascular and cerebrovascular diseases (such as hypertension, atrial fibrillation, myocardial infarction, heart failure, and stroke), and respiratory diseases (including asthma and chronic obstructive pulmonary disease). This article systematically reviews the physiological compensatory mechanisms induced by cold exposure and recent research advances concerning their mediation of common cold-related diseases, thereby providing a theoretical basis for the precision prevention and treatment of cold-associated disorders.

Key words: cold exposure, energy metabolism reprogramming, vascular dysfunction, immune dysregulation, renin-angiotensin-aldosterone system, pathophysiological mechanisms

CLC Number: